These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2172826)

  • 1. The bivalent ligand approach in the design of highly selective opioid receptor antagonists.
    Portoghese PS
    NIDA Res Monogr; 1990; 96():3-20. PubMed ID: 2172826
    [No Abstract]   [Full Text] [Related]  

  • 2. Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists.
    Portoghese PS
    Trends Pharmacol Sci; 1989 Jun; 10(6):230-5. PubMed ID: 2549665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid antagonists: structure activity relationships.
    Zimmerman DM; Leander JD
    NIDA Res Monogr; 1990; 96():50-60. PubMed ID: 2172827
    [No Abstract]   [Full Text] [Related]  

  • 4. Peptide and nonpeptide ligands for opioid receptors.
    Misicka A
    Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine receptor--design of ligands.
    Carroll FI; Philip A; Lewin AH
    NIDA Res Monogr; 1990; 96():112-21. PubMed ID: 2233991
    [No Abstract]   [Full Text] [Related]  

  • 6. Conformation-activity relationships of opioid peptides with selective activities at opioid receptors.
    Hruby VJ; Agnes RS
    Biopolymers; 1999; 51(6):391-410. PubMed ID: 10797229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid receptors: development of selective peptidomimetics with agonist or antagonist activity.
    Ronsisvalle G; Pappalardo MS; Spampinato S; Mele A
    Farmaco; 1991 Jan; 46(1 Suppl):171-5. PubMed ID: 1649610
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross-protection of mu and delta opioid receptors in the mouse vas deferens.
    Sheehan MJ; Hayes AG; Tyers MB
    NIDA Res Monogr; 1986; 75():85-8. PubMed ID: 2829013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.
    Watson B; Meng F; Akil H
    Neurobiol Dis; 1996 Feb; 3(1):87-96. PubMed ID: 9173916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity of opioid agonists and antagonists for the various opioid receptor types.
    Takemori AE; Portoghese PS
    Psychopharmacol Bull; 1985; 21(3):464-5. PubMed ID: 2994158
    [No Abstract]   [Full Text] [Related]  

  • 11. Structural requirements for affinity and intrinsic activity at the opiate receptor defined in 4-phenylpiperidine and related series.
    Zimmeman DM; Smits SE; Hynes MD; Cantrell BE; Reamer M; Nickander R
    NIDA Res Monogr; 1982 Apr; 41():112-8. PubMed ID: 6289111
    [No Abstract]   [Full Text] [Related]  

  • 12. Opioid agonist and antagonist bivalent ligands as receptor probes.
    Portoghese PS; Ronsisvalle G; Larson DL; Yim CB; Sayre LM; Takemori AE
    Life Sci; 1982 Sep 20-27; 31(12-13):1283-6. PubMed ID: 6292615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine.
    Thomas JB; Fall MJ; Cooper JB; Rothman RB; Mascarella SW; Xu H; Partilla JS; Dersch CM; McCullough KB; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 1998 Dec; 41(26):5188-97. PubMed ID: 9857089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the message-address concept in the design of highly potent and selective non-peptide delta opioid receptor antagonists.
    Portoghese PS; Sultana M; Nagase H; Takemori AE
    J Med Chem; 1988 Feb; 31(2):281-2. PubMed ID: 2828619
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A steric theory of opioid agonists, antagonists, agonist-antagonists, and partial agonists.
    Martin WR
    NIDA Res Monogr; 1984 Mar; 49():16-23. PubMed ID: 6090916
    [No Abstract]   [Full Text] [Related]  

  • 17. New delta-receptor antagonists.
    Thornber CW; Shaw JS; Miller L; Hayward CF; Morley JS; Timms D; Wilkinson A
    NIDA Res Monogr; 1986; 75():177-80. PubMed ID: 2828968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of opioids.
    Martin WR
    Pharmacol Rev; 1983 Dec; 35(4):283-323. PubMed ID: 6144112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of opioid receptor ligands injected into the rostral lateral hypothalamus on c-fos and feeding behavior.
    Li D; Olszewski PK; Shi Q; Grace MK; Billington CJ; Kotz CM; Levine AS
    Brain Res; 2006 Jun; 1096(1):120-4. PubMed ID: 16716266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular effects of opioid receptor blocker naloxone].
    Osadchiĭ OE; Pokrovskiĭ VM
    Eksp Klin Farmakol; 2001; 64(3):72-5. PubMed ID: 11558446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.